Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Omipalisib | 0.0016596 | uM | 3 | 312.50 | 257.33 | 357.00 | 443.75 | 0.8045 | 0.5166 |
| SK-BR-3 | Taxol | 0.31623 | uM | 3 | 312.50 | 257.33 | 249.00 | 443.75 | 0.5611 | -0.0410 |
| SK-BR-3 | Taxol | 1 | uM | 3 | 312.50 | 257.33 | 221.00 | 443.75 | 0.4980 | -0.1760 |
| SK-BR-3 | Omipalisib | 3.1623 | uM | 3 | 312.50 | 257.33 | 238.00 | 443.75 | 0.5363 | -0.0946 |
| SK-BR-3 | Palbociclib | 10 | uM | 3 | 312.50 | 257.33 | 351.00 | 443.75 | 0.7910 | 0.4842 |
| SK-BR-3 | Taxol | 0.01 | uM | 3 | 312.50 | 257.33 | 190.00 | 443.75 | 0.4282 | -0.3202 |
| SK-BR-3 | Palbociclib | 0.1 | uM | 3 | 312.50 | 257.33 | 299.00 | 443.75 | 0.6738 | 0.2103 |
| SK-BR-3 | Methotrexate | 1 | uM | 3 | 312.50 | 257.33 | 387.00 | 443.75 | 0.8721 | 0.6805 |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 447.00 | 443.75 | 1.0073 | 1.0187 | |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 438.00 | 443.75 | 0.9870 | 0.9671 | |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 353.00 | 443.75 | 0.7955 | 0.4950 | |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 240.00 | 443.75 | 0.5409 | -0.0849 | |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 455.00 | 443.75 | 1.0254 | 1.0647 | |
| SK-BR-3 | Taxol | 0.00033113 | uM | 3 | 312.50 | 257.33 | 396.00 | 443.75 | 0.8924 | 0.7304 |
| SK-BR-3 | Methotrexate | 0.01 | uM | 3 | 312.50 | 257.33 | 494.00 | 443.75 | 1.1132 | 1.2924 |
| SK-BR-3 | Omipalisib | 1 | uM | 3 | 312.50 | 257.33 | 169.00 | 443.75 | 0.3809 | -0.4143 |
| SK-BR-3 | Methotrexate | 10 | uM | 3 | 312.50 | 257.33 | 521.00 | 443.75 | 1.1741 | 1.4530 |
| SK-BR-3 | Palbociclib | 1 | uM | 3 | 312.50 | 257.33 | 313.00 | 443.75 | 0.7054 | 0.2829 |
| SK-BR-3 | Methotrexate | 0.31623 | uM | 3 | 312.50 | 257.33 | 431.00 | 443.75 | 0.9713 | 0.9272 |
| SK-BR-3 | Taxol | 0.0031623 | uM | 3 | 312.50 | 257.33 | 264.00 | 443.75 | 0.5949 | 0.0331 |
| SK-BR-3 | Methotrexate | 0.1 | uM | 3 | 312.50 | 257.33 | 396.00 | 443.75 | 0.8924 | 0.7304 |
| SK-BR-3 | Omipalisib | 0.31623 | uM | 3 | 312.50 | 257.33 | 231.00 | 443.75 | 0.5206 | -0.1283 |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 526.00 | 443.75 | 1.1854 | 1.4830 | |
| SK-BR-3 | Palbociclib | 0.31623 | uM | 3 | 312.50 | 257.33 | 449.00 | 443.75 | 1.0118 | 1.0301 |
| SK-BR-3 | Omipalisib | 0.01 | uM | 3 | 312.50 | 257.33 | 352.00 | 443.75 | 0.7932 | 0.4896 |